Arcus Biosciences (RCUS) Share-based Compensation (2017 - 2026)
Arcus Biosciences' Share-based Compensation came in at $15 million for Q2 2026, unchanged from $15 million a year earlier and down 21.1% from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) Share-based Compensation (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Arcus Biosciences reported Share-based Compensation of $63 million, down 6.0% year-over-year; for FY2025, it came in at $60 million, down 21.1% from FY2024.
- Share-based Compensation carries a five-year compound annual growth rate of 22.2% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $76 million in FY2024 (+4.1%), $73 million in FY2023 (+12.3%), $65 million in FY2022 (+18.2%) and $55 million in FY2021 (+150.0%).
- The five-year range for quarterly Share-based Compensation is $14 million (Q3 2025) to $20 million (Q2 2024).
- Year-over-year, Share-based Compensation increased in two of the last eight quarters, with an average decline of 8.0%.
- The fastest year-over-year change in Share-based Compensation over five years came in Q3 2021 (growth of 143.0%), and the weakest in Q3 2025 (a decline of 26.3%).
- Business Quant data shows RCUS's Share-based Compensation at $19 million (Q1 2026), $15 million (Q4 2025) and $14 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Arcus Biosciences | 3.00 Bn | -337.34 Mn | - | 15.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.00 Mn |
| Mar 31, 2026 | 19.00 Mn |
| Dec 31, 2025 | 15.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 15.00 Mn |
| Mar 31, 2025 | 16.00 Mn |
| Dec 31, 2024 | 17.00 Mn |
| Sep 30, 2024 | 19.00 Mn |
| Jun 30, 2024 | 20.00 Mn |
| Mar 31, 2024 | 20.00 Mn |
| Dec 31, 2023 | 18.00 Mn |
| Sep 30, 2023 | 18.00 Mn |
| Jun 30, 2023 | 18.00 Mn |
| Mar 31, 2023 | 19.00 Mn |
| Dec 31, 2022 | 17.00 Mn |
| Sep 30, 2022 | 16.26 Mn |
| Jun 30, 2022 | 15.00 Mn |
| Mar 31, 2022 | 17.00 Mn |
| Dec 31, 2021 | 14.29 Mn |
| Sep 30, 2021 | 14.59 Mn |
API Access
Arcus Biosciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();